The US Food and Drug Administration (FDA) has announced it has approved colon cancer drug, Zaltrap, for use in combination with a folinic acid, fluorouracil and iriontecan (FOLFIRI) chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback